EGFR and breast carcinoma: For example, the anti-epidermal growth factor receptor (EGFR) [10,11], HER2 [12] and vascular endothelial growth factor (VEGF) [13,14] antibodies or peptides have been linked to liposomal system to deliver doxorubicin or other medicines to breast cancers and other tumors.